Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 30.40
+1.95 (6.85%)
At close: Jan 9, 2026
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 608.44 million as of January 9, 2026. Its market cap has increased by 273.13% in one year.
Market Cap
608.44M
Enterprise Value
617.20M
Revenue
55.93M
Ranking
n/a
PE Ratio
27.34
Stock Price
30.40
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 608.44M, an increase of 96.88%. That is a compound annual growth rate of 3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 608.44M | 27.81% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 291.07B |
| Novartis AG | 218.82B |
| Galderma Group AG | 39.22B |
| Lonza Group AG | 38.88B |
| Alcon | 31.29B |
| Sandoz Group AG | 26.08B |
| Straumann Holding AG | 15.98B |
| Sonova Holding AG | 12.61B |